{
    "root": "2f9bfd2f-129e-a52a-e063-6294a90a9856",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Pantoprazole Sodium",
    "value": "20250305",
    "ingredients": [
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13"
        },
        {
            "name": "PANTOPRAZOLE SODIUM",
            "code": "6871619Q5X"
        }
    ],
    "indications": "Pantoprazole Sodium Delayed-Release Tablets, USP are indicated for:",
    "contraindications": "Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD ( 2.1 ) Adults 40 mg Once Daily for up to 8 wks Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis ( 2.1 ) Adults 40 mg Once Daily Controlled studies did not extend beyond 12 months Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome ( 2.1 ) Adults 40 mg Twice Daily See full prescribing information for administration instructions",
    "warningsAndPrecautions": "How Supplied\n                     \nPantoprazole Sodium Delayed-Release Tablets, USP are supplied as 40 mg white to off-white, oval-shaped coated tablet,\n  \ndebossed with \"17\" on one side and are available as follows:\n  \nBoxes of 10 x 10 UD 100 NDC 63739-564-10\n \n                  \n                  \n                     Storage\n                     \nStore Pantoprazole Sodium Delayed-Release Tablets, USP at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C\n  \n(59° to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "Pantoprazole is contraindicated in patients with known hypersensitivity to any component of the formulation or any\n                  \n                  substituted benzimidazole. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema,\n  \nbronchospasm, acute tubulointerstitial nephritis, and urticaria\n   [see Warnings and Precautions (5.2) and Adverse Reactions (6)].​\n  \n                  \n                  \n                  \n                     Proton pump inhibitors (PPIs), including Pantoprazole, are contraindicated in patients receiving rilpivirine-containing products \n   [see Drug Interactions ( \n    7)]."
}